Management and outcome. In both individual and daily group sessions, it was pointed out to her how she avoided dealing with stressful situations; this brought about a rise of tension, which made her headaches worse. Joint interviews were held with her mother, and there was an improvement in their relationship. It was explained to the patient that withdrawal headaches can occur with Migril, and it was this that led to her taking daily tablets to ward off these symptoms; also the potentially dangerous results of continuous ingestion of ergotamine were stressed.
The Migril was then abruptly stopped. The follow ing day the patient experienced a severe unilateral headache with nausea and vomiting, and this lasted for four days. Subsequently she was completely free from headaches, apart from a relatively mild attack three weeks later coinciding with the stress of applying for a job. During this time urine tests for caffeine and cyclizine were negative, confirming that she was no longer taking Migril. Her peripheral circulation improved and the pruritus and cyanosis disappeared.
At the time of discharge, four weeks after stopping the Migril, she was working, much more confident in her outlook and remained free from medication and 
Management and outcome.
As an out-patient, an attempt had been made to relate the patient's tension to his unsatisfactory marital relationship, but this only increased his level of anxiety and the severity of his migraine, necessitating his admission. However, as an in-patient he remained resistant to further exploration of his marital problems, insisted on taking Migril nightly, and finally discharged himself from hospital.
Case 3
A n-year-old woman admitted to the Maudsley Hospital in 1957 for treatment of migraine and with a two-year history of daily, self-administered, injections of ergotamine. There was no family history of mental illness, though her younger sister suffered from headaches. Her parents were very strict. The patient was always reserved and sensitive, anxious about other people's opinion of her and always seeking approval. At the age of 22 she married, having just become pregnant. She felt ashamed of this premarital pregnancy and she found her husband inconsiderate and lacking in affection and understanding.
There was thus much marital tension and sexual relationships ceased two years before her admission to the Maudsley Hospital.
Her migraine started at the age of io, often ergotamine a week.
Xanthines have a similar but milder effect to ergotamine on the cerebral vasculature, and withdrawal headaches can occur with these also (Goodman and Gilman, 1970) . Further xan thines have been shown to enhance the absorp tion of ergot derivatives (Berde et al., 1969) (Friedman and Elkind, 1963 ; Graham, 1964; Curran and Lance, 1964) . It is thought to have its effect by maintaining a state of cerebral vasoconstriction, but in a different manner to ergotamine (Dalessio et al., 1961; Dc La Lande et al., 1966; Lance et al., 1970) . Both tolerance and withdrawal headaches have been described with methysergide (Graham, 1964) . One can therefore appreciate that, as with ergotamine, a patient could find himself taking increasing daily amounts of this drug and have consider able difficulty in arresting or reversing the process. The authors have not found any pre vious reports in the literature of this pheno. menon developing in relationship to methy sergide.
All patients in this series were unduly anxious, tended to â€˜¿ bottle up' their feelings, had low stress tolerance and were subjected to prolonged tension, which served as the main precipitant forthe attacksof migraine.We are led therefore to agree that â€˜¿ sinceemotional factors appear to be the most frequent precipitants of migraine attacks, the psychological background is pro perly a part of the initial evaluation as well as of paramount importance in treatment' (Fried man, 1968 The effects of tolerance and withdrawal head aches as factors contributing to the abuse of these drugs are discussed. Attention is drawn to the dangers of such abuse in patients who are unduly anxious and are subjected to prolonged stress.The need to treat the patient as a whole is emphasized in relationship to the prevention of abuse of antimigraine drugs and to the management of such abuse if it develops.
